Therefore, a higher proportion of IDH mutations in our study is a consequence of more frequent equivocal decisions at a multidisciplinary tumor board in IDHm cases, and represents a selection of notably difficult cases [31]. This evidence concerns the gene IDH1 and neoplasm.